Quality of life outcomes associated with variable posttransplant prednisone dosing regimens

Donna Hathaway, R. P. Winsett, J. Milstead, Mona Wicks, A. O. Gaber

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Prednisone tapering has become more common in the management of transplant recipients. Benefits of this practice, however, must be weighed against the risks. This study identified outcomes associated with variable low dose prednisone protocols. The study sample included 98 kidney and kidney-pancreas transplant recipients 1 year after transplant. Graft function, side effects of steroid therapy, and quality of life were recorded on patients receiving 0 (n = 5), 1 to 5 (n = 4), 5 to 7.5 (n = 5), 7.5 to 10 (n = 21), and greater than 10 mg/d prednisone (n = 63). Despite the fact that patients were assigned to the low dose groups because they were at risk for or already experiencing steroid induced side effects, the low dose groups presented side effect and quality of life profiles similar to or better than those of the standard dose group.

Original languageEnglish (US)
Pages (from-to)64-68
Number of pages5
JournalJournal of Transplant Coordination
Volume6
Issue number2
DOIs
StatePublished - Jan 1 1996
Externally publishedYes

Fingerprint

Prednisone
Quality of Life
Steroids
Transplants
Kidney
Pancreas
Outcome Assessment (Health Care)
Transplant Recipients
Therapeutics

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

Quality of life outcomes associated with variable posttransplant prednisone dosing regimens. / Hathaway, Donna; Winsett, R. P.; Milstead, J.; Wicks, Mona; Gaber, A. O.

In: Journal of Transplant Coordination, Vol. 6, No. 2, 01.01.1996, p. 64-68.

Research output: Contribution to journalArticle

@article{e28f53c479a2491fb6b5c6acefb00851,
title = "Quality of life outcomes associated with variable posttransplant prednisone dosing regimens",
abstract = "Prednisone tapering has become more common in the management of transplant recipients. Benefits of this practice, however, must be weighed against the risks. This study identified outcomes associated with variable low dose prednisone protocols. The study sample included 98 kidney and kidney-pancreas transplant recipients 1 year after transplant. Graft function, side effects of steroid therapy, and quality of life were recorded on patients receiving 0 (n = 5), 1 to 5 (n = 4), 5 to 7.5 (n = 5), 7.5 to 10 (n = 21), and greater than 10 mg/d prednisone (n = 63). Despite the fact that patients were assigned to the low dose groups because they were at risk for or already experiencing steroid induced side effects, the low dose groups presented side effect and quality of life profiles similar to or better than those of the standard dose group.",
author = "Donna Hathaway and Winsett, {R. P.} and J. Milstead and Mona Wicks and Gaber, {A. O.}",
year = "1996",
month = "1",
day = "1",
doi = "10.7182/prtr.1.6.2.n2pl238265177gpm",
language = "English (US)",
volume = "6",
pages = "64--68",
journal = "Progress in Transplantation",
issn = "1526-9248",
publisher = "InnoVision Communications",
number = "2",

}

TY - JOUR

T1 - Quality of life outcomes associated with variable posttransplant prednisone dosing regimens

AU - Hathaway, Donna

AU - Winsett, R. P.

AU - Milstead, J.

AU - Wicks, Mona

AU - Gaber, A. O.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - Prednisone tapering has become more common in the management of transplant recipients. Benefits of this practice, however, must be weighed against the risks. This study identified outcomes associated with variable low dose prednisone protocols. The study sample included 98 kidney and kidney-pancreas transplant recipients 1 year after transplant. Graft function, side effects of steroid therapy, and quality of life were recorded on patients receiving 0 (n = 5), 1 to 5 (n = 4), 5 to 7.5 (n = 5), 7.5 to 10 (n = 21), and greater than 10 mg/d prednisone (n = 63). Despite the fact that patients were assigned to the low dose groups because they were at risk for or already experiencing steroid induced side effects, the low dose groups presented side effect and quality of life profiles similar to or better than those of the standard dose group.

AB - Prednisone tapering has become more common in the management of transplant recipients. Benefits of this practice, however, must be weighed against the risks. This study identified outcomes associated with variable low dose prednisone protocols. The study sample included 98 kidney and kidney-pancreas transplant recipients 1 year after transplant. Graft function, side effects of steroid therapy, and quality of life were recorded on patients receiving 0 (n = 5), 1 to 5 (n = 4), 5 to 7.5 (n = 5), 7.5 to 10 (n = 21), and greater than 10 mg/d prednisone (n = 63). Despite the fact that patients were assigned to the low dose groups because they were at risk for or already experiencing steroid induced side effects, the low dose groups presented side effect and quality of life profiles similar to or better than those of the standard dose group.

UR - http://www.scopus.com/inward/record.url?scp=0029831864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029831864&partnerID=8YFLogxK

U2 - 10.7182/prtr.1.6.2.n2pl238265177gpm

DO - 10.7182/prtr.1.6.2.n2pl238265177gpm

M3 - Article

VL - 6

SP - 64

EP - 68

JO - Progress in Transplantation

JF - Progress in Transplantation

SN - 1526-9248

IS - 2

ER -